FDA Inspection 1260213 - Biogenesis, Inc - February 27, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Biogenesis, Inc, with an inspection on February 27, 2025, issued by the New Jersey District Office, covering human drugs.

Company: Biogenesis, Inc
Inspection Date: February 27, 2025
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · a36a341e-ba5d-4181-ba30-4c5bdc6f36e0

Violation Codes1

21 CFR 211.67(a)

Full citation text and observation details available on the Dashboard.